603368.SH
柳药集团
SSE · Healthcare · Medical - Distribution · CN
CNY 15.74
−0.88%Year over year
Reported trailing growth
- Revenue
- +1.3%
- EBITDA
- —
- EBIT
- -11.0%
- EPS
- -19.7%
- Free cash flow
- +31.5%
- Operating cash flow
- +27.1%
Forward estimates
Based on analyst estimates
- Revenue
- -75.5%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +3.2%
- EBITDA
- -0.6%
- EBIT
- -0.3%
- Net income
- +0.4%
- EPS
- -2.6%
- Free cash flow
- +40.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026